Data / Form D filings / Biolytx Pharmaceuticals Corp
Biolytx Pharmaceuticals Corp: Form D filing
Biolytx Pharmaceuticals Corp, a pharmaceuticals company in Oklahoma City, OK, filed a Form D with the SEC in 2015. The latest, on October 29, 2015, reports $1.3 million sold of a $1.4 million offering to 12 investors.
Find out what Biolytx Pharmaceuticals Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 800 RESEARCH PARKWAY, SUITE 334, Oklahoma City, OK, 73104
- Phone
- (405) 271-6593
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1656890
The full lists. Form D filings in Oklahoma: 227 rows, $11.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2015 | New notice | $1,417,971 | $1,317,971 | $100,000 | 12 | Oct 16, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas A Branch | Executive Officer | |
| William A Hagstrom | Director | |
| H Anne Pereira | Executive Officer, Director |
Every Form D from the week of Oct 26, 2015 · All recent filings in Oklahoma · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Biolytx Pharmaceuticals Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.